Alzheimer Disease Clinical Trial
Official title:
A Mobile Informatics Solution to Aid in Memory
Verified date | April 2024 |
Source | University of Minnesota |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The researchers propose to develop an informatics system to assist people with memory impairment. Persons with Memory Concern (PWMC) recognize the faces they see daily, such as a spouse or caregiver, but they may confuse visiting friends and grandchildren or they may not match names with faces well. The inability to remember names or relationships contributes to isolation and deeply affects their social lives. The proposed solution is a Smartwatch Reminder (SR) system to conspicuously provide this information to the PWMC when needed. The system will be evaluated on the target persons with memory concern population to measure engagement and improvements in social interactions and quality of life.
Status | Completed |
Enrollment | 162 |
Est. completion date | April 1, 2024 |
Est. primary completion date | April 1, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 21 Years and older |
Eligibility | Inclusion criteria for PWMC are as follows: - English speaking - a physician diagnosis of early-stage Alzheimer's disease or mild-to-moderate cognitive impairment - no history of serious mental illness (i.e., any major psychiatric disorder) Inclusion criteria for care partners of PWMC are as follows: - English speaking - 21 years of age or over - self-identifies as someone who provides assistance to the PWMC because of their memory loss (these individuals are called ''care partners,'' as these individuals may or may not provide the intensive hands-on care typical of ''caregivers'') - plans to remain in the area for at least 6 months in order to reduce loss to follow-up - indicates a willingness to use the smartwatch system Exclusion Criteria for PWMC are as follows: - non-English speaking - no physician diagnosis of early-stage Alzheimer's disease or mild-to-moderate cognitive impairment - a history of serious mental illness (i.e., any major psychiatric disorder) Exclusion criteria for care partners of PWMC are as follows: - non-English speaking - under 21 years of age - does not identify as someone who provides assistance to the PWMC because of their memory loss - does not plan on remaining in the area for at least 6 months - does not indicate a willingness to use the smartwatch system |
Country | Name | City | State |
---|---|---|---|
United States | University of Minnesota | Minneapolis | Minnesota |
Lead Sponsor | Collaborator |
---|---|
University of Minnesota | Advanced Medical Electronics, Brown University, University of Michigan |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in PWMC Social Interaction Frequency | 8-item measure of the frequency of the PWMC's social interactions | Baseline, 3-, and 6-months | |
Primary | Change in PWMC Social Interaction Quality | 8-item measure of the quality of the PWMC's social interactions (scores range from 8 to 40; higher scores suggest greater satisfaction with social interactions) | Baseline, 3-, and 6-months | |
Primary | Change in PWMC Quality of Life | 21-item adapted Dementia Quality of Life (DQoL) measure (scores range from 0 to 105; higher scores indicate higher quality of life) | Baseline, 3-, and 6-months | |
Secondary | Change in Care Partner Psychosocial Well-Being | 11-item Eriksonian Psychosocial Stage Inventory (scores range from 11 to 55; higher scores suggest greater well-being) | Baseline, 3-, and 6-months | |
Secondary | Change in Care Partner Depression | 10-item Center for Epidemiological Studies - Depression Scale (scores range from 0 to 30; higher scores suggest more severe depression symptoms) | Baseline, 3-, and 6-months | |
Secondary | Change in Social Support | 8-item scale to assess affective assistance by care partner's social network (scores range from 8 to 40; higher scores suggest higher affective assistance by social network) | Baseline, 3-, and 6-months | |
Secondary | Change in Social Engagement | 6-item Lubben Social Network Scale (LSNS-6) (scores range from 0 to 30; higher scores suggest higher risk of social isolation) | Baseline, 3-, and 6-months | |
Secondary | Change in Negative Health Transitions | 1-item to assess change in living or care situation and mortality | Baseline, 3-, and 6-months | |
Secondary | Change in Relationship Quality | 6-item version of the Relationship Assessment Scale (scores range from 0 to 30; higher scores suggest higher satisfaction with the relationship) | Baseline, 3-, and 6-months | |
Secondary | Change in Pleasant Events Schedule | 20-items adapted measure of events and activities (PES-AD) (scores range from 0 to 60; higher scores suggest greater enjoyment with events and activities) | Baseline, 3-, and 6-months | |
Secondary | Change in Community Engagement | 15-item survey developed to evaluate the PWMC's typical social interactions and destinations accessed outside of the home (scores range from 0 to 75; higher scores indicate greater community engagement) | Baseline, 3-, and 6-months | |
Secondary | Change in PWMC Functional Status | 12-item survey to assess Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL) (scores range from 0 to 36; higher scores indicate greater impairment in function) | Baseline, 3-, and 6-months | |
Secondary | Change in Memory Impairment | 8-item survey to evaluate level of memory impairment of PWMC (scores range from 8 to 40; higher scores indicate greater memory impairment) | Baseline, 3-, and 6-months | |
Secondary | Change in Care Partner Reactions to Memory and Behavioral Problems | 24-item Revised Memory and Behavior Problem Checklist (scores range from 0 to 96; higher scores indicate greater distress associated with problems) | Baseline, 3-, and 6-months | |
Secondary | Change in Care Partner Quality of Life Ladder | Cantril's Ladder (scores range from 0 to 10; higher scores suggest higher quality of life) | Baseline, 3-, and 6-months | |
Secondary | Change in Care Partner Loneliness in Relationship | UCLA Loneliness Scale (scores range from 20 to 80; higher scores indicate greater loneliness) | Baseline, 3-, and 6-months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
Completed |
NCT04079803 -
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
|
Phase 2 | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Recruiting |
NCT04520698 -
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
|
N/A | |
Active, not recruiting |
NCT04606420 -
Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
Terminated |
NCT03672474 -
REGEnLIFE RGn530 - Feasibility Pilot
|
N/A | |
Completed |
NCT03430648 -
Is Tau Protein Linked to Mobility Function?
|
||
Recruiting |
NCT04949750 -
Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Recruiting |
NCT05288842 -
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
|
||
Completed |
NCT06194552 -
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
|
Phase 1 | |
Completed |
NCT03239561 -
Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
|
Early Phase 1 | |
Completed |
NCT03184467 -
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Terminated |
NCT03487380 -
Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease
|
N/A | |
Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
Recruiting |
NCT05328115 -
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
|
Phase 1 | |
Completed |
NCT05562583 -
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
|
N/A |